Caroline Chevalier
Plus aucun poste en cours
Profil
Caroline Chevalier worked as a Senior Director of Total Rewards & HR Operations at Tesaro, Inc. and as a Purchasing Director at Gestionova SAS.
She also worked as a Vice President of Human Resources at Deciphera Pharmaceuticals, Inc. from 2018 to 2021.
Ms. Chevalier received an undergraduate degree from Boston College.
Anciens postes connus de Caroline Chevalier
| Sociétés | Poste | Fin |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Responsable des Ressources Humaines | 01/10/2021 |
| TESARO INC | Responsable des Ressources Humaines | - |
Gestionova SAS
 Gestionova SAS Miscellaneous Commercial ServicesCommercial Services Gestionova SAS operates as a holding company with interests in the provision of maintenance and building services. Through its subsidiaries, it offers solutions for air conditioning, heating, plumbing, waterproofing, and electricity. The company was founded on October 5, 1998 and is headquartered in Velizy-Villacoublay, France. | Corporate Officer/Principal | - |
Formation de Caroline Chevalier
| Boston College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Gestionova SAS
Gestionova SAS Miscellaneous Commercial ServicesCommercial Services Gestionova SAS operates as a holding company with interests in the provision of maintenance and building services. Through its subsidiaries, it offers solutions for air conditioning, heating, plumbing, waterproofing, and electricity. The company was founded on October 5, 1998 and is headquartered in Velizy-Villacoublay, France. | Commercial Services |
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
